Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting tumor microenvironment in ovarian cancer: Premise and promise
Yuting Jiang, Chengdi Wang, Shengtao Zhou
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188361-188361
Closed Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
Tumor microenvironment in ovarian cancer peritoneal metastasis
Shuangshuang Mei, Xing Chen, Kai Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 46
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
Jingzhe Wang, Bakhos A. Tannous, Mark C. Poznansky, et al.
Pharmacological Research (2020) Vol. 159, pp. 105010-105010
Closed Access | Times Cited: 94
Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Yuqi Yang, Tianjiao Zhao, Qiaohui Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 28
Open Access | Times Cited: 40
Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products
Holya A. Lafta, Ali Hamid AbdulHussein, Saif A. J. Al-Shalah, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1104-1122
Closed Access | Times Cited: 39
Sulforaphane as a potential remedy against cancer: Comprehensive mechanistic review
Iahtisham Ul-Haq, Sipper Khan, Kanza Aziz Awan, et al.
Journal of Food Biochemistry (2021) Vol. 46, Iss. 3
Open Access | Times Cited: 51
Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
Emanuela Anastasi, Antonella Farina, Teresa Granato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10479-10479
Open Access | Times Cited: 18
Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling
Cong Zhang, Jinxiang Yang, Siyu Chen, et al.
The EPMA Journal (2024) Vol. 15, Iss. 3, pp. 525-544
Closed Access | Times Cited: 6
The role of caspase-8 in the tumor microenvironment of ovarian cancer
Izabela Kostova, Ranadip Mandal, Sven Becker, et al.
Cancer and Metastasis Reviews (2020) Vol. 40, Iss. 1, pp. 303-318
Open Access | Times Cited: 46
How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer
Alessandra Ferraresi, Carlo Girone, Andrea Esposito, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 45
Insights into the Role of Oxidative Stress in Ovarian Cancer
Dan‐Ni Ding, Liangzhen Xie, Ying Shen, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 40
Growth differentiation factor-15 promotes immune escape of ovarian cancer via targeting CD44 in dendritic cells
Yunge Gao, Ying Xu, Shuhui Zhao, et al.
Experimental Cell Research (2021) Vol. 402, Iss. 1, pp. 112522-112522
Closed Access | Times Cited: 37
GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis
Chao Chen, Li Zhang, Zhengyi Ruan
Molecular Pharmaceutics (2022) Vol. 20, Iss. 2, pp. 971-986
Closed Access | Times Cited: 27
Integrated analysis of tumor-associated macrophage infiltration and prognosis in ovarian cancer
Qianxia Tan, Huining Liu, Jie Xu, et al.
Aging (2021) Vol. 13, Iss. 19, pp. 23210-23232
Open Access | Times Cited: 32
Ovarian cancer‐specific dysregulated genes with prognostic significance: scRNA‐Seq with bulk RNA‐Seq data and experimental validation
Chang Liu, Ying Zhang, Xiaohan Li, et al.
Annals of the New York Academy of Sciences (2022) Vol. 1512, Iss. 1, pp. 154-173
Closed Access | Times Cited: 22
Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer
Lanmei Gao, Wenying Jiang, Qiuyuan Yue, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109335-109335
Closed Access | Times Cited: 21
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Wojciech Szymanowski, A. Szymanowska, Anna Bielawska, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5300-5300
Open Access | Times Cited: 12
Exploring prognostic indicators in the pathological images of ovarian cancer based on a deep survival network
Meixuan Wu, Chengguang Zhu, Jiani Yang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 11
HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process
Sijia Ma, Jia Wang, Zhiwei Cui, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Peritumoral MRI Radiomics Features Increase the Evaluation Efficiency for Response to Chemotherapy in Patients With Epithelial Ovarian Cancer
Yongai Li, Junming Jian, Huijie Ge, et al.
Journal of Magnetic Resonance Imaging (2024) Vol. 60, Iss. 6, pp. 2718-2727
Closed Access | Times Cited: 4
Spatial tumor immune microenvironment phenotypes in ovarian cancer
Claudia Mateiou, Lavanya Lokhande, Lan Hoa Diep, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Regulation of Age-Related Lipid Metabolism in Ovarian Cancer
Jihua Feng, Clay Douglas Rouse, Lila Taylor, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 320-320
Open Access
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Caixia Wang, Changsheng Peng, Chuan Xie
Open Medicine (2025) Vol. 20, Iss. 1
Open Access
GPR137-RAB8A activation promotes ovarian cancer development via the Hedgehog pathway
Chao Tang, Lin Li, Chongying Zhu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer
Connor Wang, Maria Gomez-Roas, Emily Hinchcliff
Advances in Oncology (2025)
Closed Access
Page 1 - Next Page

Scroll to top